Blue Cross Blue Shield of Texas - Exchange (BlueAdvantage)
Blue Cross Blue Shield of Texas - HMO/PPO
Blue Cross Blue Shield of Texas - HPN/EPO (Narrow Network)
Blue Cross Blue Shield of Texas - Medicaid-STAR
Blue Cross Blue Shield of Texas - Medicare Advantage HMO
Blue Cross Blue Shield of Texas - Medicare Advantage PPO
Blue Cross Blue Shield of Texas - Narrow HMO (Blue Essentials)
Blue Cross Blue Shield of Texas - Narrow HMO (Blue Premier)
Blue Cross Blue Shield of Texas - Traditional
Blue Cross Blue Shield of Texas - Transplant Programs
Care Improvement Plus - Medicare Advantage-SNP
Cenpatico - Medicaid-CHIP
Cenpatico - Medicaid-STAR
Cenpatico - Medicaid-STAR Health (Foster Care)
Cenpatico - Medicare Advantage
Community First Health Plans - HMO/Exchange (EPO)
Community First Health Plans - Medicaid-CHIP
Community First Health Plans - Medicaid-CHIP Perinate
Community First Health Plans - Medicaid-STAR
Community First Health Plans - Medicaid-STAR Kids
Community First Health Plans - Medicare Advantage HMO
Coventry - HMO/PPO
Coventry - Work Comp / Auto
Decent Health Plan - Commercial EPO
EBSO - TPA
Entrust - TPA
FirstCare (Part of Scott & White Health Plans) - Medicaid-STAR
Healthsmart - PPO
Humana - Commercial Behavioral Health
Humana - Exchange (HMOx)
Humana - HMO/PPO/Behavioral Health
Humana - Medicare Advantage Behavioral Health
Humana - Medicare Advantage HMO (Gold)
Humana - Medicare Advantage PPO
Humana - National Transplant Network
Humana Military - TRICARE
Imperial Health Plan - Medicare Advantage
Independent Medical Systems (IMS) - PPO
Interlink - Transplant
LifeTrac - Transplant
Magellan - Commercial and Medicaid Behavioral Health
Molina - Commercial Exchange
Molina - Medicaid-CHIP
Molina - Medicaid-CHIP Perinate
Molina - Medicaid-STAR
Molina - Medicare Advantage
Molina - Medicare-Medicaid Duals
OptumHealth - Transplant
Point Comfort Underwriters (PCU) - Refugee Medical Assistance
Point Comfort Underwriters (PCU) - Unaccompanied Children
Preferred Provider Health Plan (PPHP) - Medicare Advantage I-SNP
Prime Health Services - Medicare Advantage
Prime Health Services- PPO
ProCare Advantage - Medicare Advantage I-SNP
Scott & White Health Plan - HMO/PPO/Medicare Advantage
Superior HealthPlan - Medicaid-CHIP
Superior HealthPlan - Medicaid-CHIP Perinate
Superior HealthPlan - Medicaid-STAR
Superior HealthPlan - Medicaid-STAR Health (Foster Care)
Superior HealthPlan - Medicaid-STAR Kids
Superior HealthPlan - Medicaid-STAR PLUS
Superior HealthPlan - Medicare Advantage (Allwell)
Superior HealthPlan - Medicare-Medicaid Duals (Allwell)
Texas Independence Health Plan - Medicare Advantage I-SNP
Three Rivers Provider Network - PPO
TriWest (via BCBSTX) - VA CCN Program
UnitedHealthcare - Medicaid-STAR
UnitedHealthcare - Medicaid-STAR Kids
UnitedHealthcare - Medicaid-STAR PLUS
UnitedHealthcare - Medicare Advantage
UnitedHealthcare - PPO
University of Incarnate Word - Direct Employer
WellCare - Medicare Advantage
WellMed - Medicare Advantage
Please contact your health insurance company to confirm provider participation. For billing and insurance questions, please call our Billing Department at 210-358-3260.
I am a Professor and Vice Chairman of the Department of Urology at UT Health San Antonio, where I head the Division of Female Urology, Neuro-Urology & Voiding Dysfunction.
I completed my undergraduate education at Brandeis University in 1987 and received my MD from UMDNJ-Rutgers Robert Wood Johnson Medical School in 1991, where I also completed my residency in urology. I completed a fellowship in Neuro-Urology, Incontinence and Urodynamics at the Baylor College of Medicine in Houston and received my Master of Science in Clinical Investigation at UT Health San Antonio.
I received my subspecialty certification in Female Pelvic Medicine and Reconstructive Surgery (FPMRS) from the American Board of Urology in June 2013. More recently, I obtained my MBA with a health care focus from the University of Texas at San Antonio College of Business in 2020 and now serve as Senior Hospital Medical Director for Quality and Safety.
As a Fellow of the American College of Surgeons, I am also a member of the American Urological Association, the American Urogynecologic Society, the International Continence Society and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU). I am on the Board of Directors for SUFU and for the Texas Urological Society where I also serve as Chair of the Education Committees for both organizations.
I served as faculty for many postgraduate courses on topics including neurourology, female urology, overactive bladder, male incontinence and voiding disorders and urodynamics. I served on the AUA Guidelines Panel on urodynamics and the AUA Guidelines Panel on female stress urinary incontinence. I am co-Chair of the AUA Guidelines Panel on neurogenic lower urinary tract dysfunction and head the SUFU OAB Clinical Care Pathway Project.
I am actively engaged in research and served as principal investigator for a variety of studies and grants including the Urinary Incontinence Treatment Network, sponsored by the NIH/NIDDK. In addition to serving on the editorial board of Drugs & Aging and BMC Urology, I serve as a reviewer for the Journal of Urology, Urology and Neurourology & Urodynamics.
My clinical practice heavily focuses on urinary incontinence, overactive bladder, neurogenic bladder and complex voiding disorders.
Articles & Publications
Rourke R, Dmochowski R, Kraus SR..Neurourology and Detrusor Compliance Abnormalties In: Urogynecology and Reconstructive Pelvic Surgery (in press). 2020..
Rourke R, Dmochowski R, Kraus SR..Overactive Bladder – Getting to Third Line Therapy In: AUA Update Series (in press). 2020..
Jun Song and Stephen R Kraus..Commentary: Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic OAB Urology Practice Update 2022 Jan.
David A Ossin, Stephen R Kraus..Commentary: Changes in the Use of Preoperative Urodynamics for Stress Urinary Incontinence Surgery After the VALUE Study Urology Practice Update 2020 Jul.
Ossin DA, Kraus SR..Commentary: Two-Year Safety and Efficacy Outcomes for the Treatment of Overactive Bladder Using a Long-Lived Rechargeable Sacral Neuromodulation System Urology Practice Update 2020 Apr.
David A. Ginsberg, Timothy B. Boone, Anne P. Cameron, Angelo Gousse, Melissa R. Kaufman, Erick Keays, Michael J. Kennelly, Gary E. Lemack, Eric S. Rovner, Lesley H. Souter, Claire C. Yang, and Stephen R. Kraus..The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation Journal of Urology 2021 Nov;206:1097-1105..
David A. Ginsberg, Timothy B. Boone, Anne P. Cameron, Angelo Gousse, Melissa R. Kaufman, Erick Keays, Michael J. Kennelly, Gary E. Lemack, Eric S. Rovner, Lesley H. Souter, Claire C. Yang, and Stephen R. Kraus..The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up Journal of Urology 2021 Nov;206:1107-1113..
Michelle Trbovich, Terry Romo, Marsha Polk, Wouter Koek, Che Kelly, Sharon Stowe, Stephen Kraus, Dean Kellogg..The Treatment of neurogenic lower urinary tract dysfunction in persons with spinal cord injury: An open label, pilot study of anticholinergic agent vs. mirabegron to evaluate cognitive impact and efficacy Spinal Cord Series and Cases 2021 Jun;7(50).
Burgio KL, Kraus SR, Johnson TM, Markland AD Vaughan CP, Li P, Redden DT, Goode PS..Combined Behavioral and Two-Drug Treatment for Lower Urinary Tract Symptoms and Overactive Bladder in Men: The COBALT Randomized Clinical Trial JAMA Intern Med 2020 Jan:411-419..
Kraus SR, Shiozawa A, Szabo SM, Qian C, Rogula B, Hairston J..Treatment Patterns and Costs Among OAB Patients Treated with Combination Oral Therapy, Sacral Nerve Stimulation, Percutaneous Tibial Nerve Stimulation, or OnabotulinumtoxinA in the United States Neurology & Urodynamics 2020 Nov;39(8):2206-2222..
Kathryn L. Burgio, Stephen R. Kraus, Diane Borello-France, Toby C. Chai, Kimberly Kenton, Patricia S. Goode, Yan Xu, John W..Kusek for the Urinary Incontinence Treatment Network . The Effect of Drug and Behavioral Therapy on Urgency and Voiding Frequency in Women with Urge Incontinence International Urogynecology Journal 2010 Jun;21(6):711-719..
Holly Richter, Michael Albo, Halina Zyczynski, Kimberly Kenton, Peggy Norton, Larry Sirls, Stephen Kraus, Gary Lemack, Heather Littman, Toby Chai..Trial of Midurethral Slings (TOMUS): A Randomized Equivalence Trial of Retropubic vs Transobturator Slings for Stress Incontinence New England Journal of Medicine 2010 Jun;362(22):2066-2076.
Kathryn L. Burgio,PhD, Stephen R. Kraus, MD, Shawn Menefee, MD, Diane Borello-France, PT, PhD, Marlene Corton, MD, Harry W. Johnson, MD, Veronica Mallett, MD, Peggy Norton, MD, Mary P. FitzGerald, MD, Kimberly J. Dandreo, MSc, Holly E. Richter, PhD, MD, Thomas Rozanski, MD, Michael Albo, MD, Halina M. Zyczynski, MD, Gary E. Lemack, MD, Toby C. Chai, MD, Salil Khandwala, MD, Jan Baker, APRN, Linda Brubaker, MD, Anne M. Stoddard, ScD, Patricia S. Goode, MD, Betsy Nielsen-Omeis, RN, BSN, Charles Nager, MD, Kimberly Kenton, MD, Sharon L. Tennstedt, PhD, John W. Kusek, PhD, T. Debuene Chang, MD, Leroy M. Nyberg, MD, PhD, William Steers, MD, for the Urinary Incontinence Treatment Network*..Behavior Therapy to Enable Women with Urge Incontinence to Discontinue Drug Treatment Annals of Internal Medicine 2008 Aug;149(3):161-169..
Michael Albo, Holly Richter, Linda Brubaker, Peggy Norton, Stephen R. Kraus, Philipe Zimmern, Toby Chai, Halina Zyczynski, Ananias Dionkno, Sharon Tenndstedt, Charles Nager, Keith Loyd, MaryPat Fitzgerald, Gary E. Lemack, Harry W. Johnson, Weny Lengm, Veronica Mallet, Anne Stoddard, Shawn Menefee, Edward Varner, Kimberly Kenton, Pam Moalli, Larry Sirls, Kimberly Dandreo, John W. Kusek, Leroy Nyberg, and William Steers, for the Urinary Incontinence Treatment Network..Burch Colposuspension versus Fasical Sling to Reduce Urinary Stress Incontinence New England Journal of Medicine 2007 May;356:2143-2155.
C.G.Roehrborn, S.A.Kaplan, S.R.Kraus, J.T.Wang, T.Bavendam and Z.Guan..Tolterodine extended release and/or Tamsulosin in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of serum prostate-specific antigen (PSA) level 2007. p. 157-158. (Urology; vol. 70, no. 3)..
Kraus S, Li J, Kristy RM, Lockefeer A, Yang H, Zhou M, Walker DR ..Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States Urology Practice 2021 Feb.
Rourke E, Meeks W, Pichardo D, Kraus SR..Impact of AUA Practice Guidelines on Urodynamic Practice Patterns Neurourology and Urodynamics 2020.
Call 210-358-3900 to request an appointment with this doctor.